In Focus

  • Renowned scientist and public health specialist to advise the GISAID Initiative on international affairs

    Dr. Marie-Paule Kieny, a former Assistant Director-General of WHO will advise GISAID on international affairs. Most recently Dr Kieny led the WHO research & development initiative during the Ebola crisis resulting in the WHO R&D Blueprint for public health emergencies, with an emphasis on enhanced global collaboration and timely sample and data sharing to support rapid emergency response.

    In a world where global emerging disease threats demand effective sharing of information, GISAID has demonstrated what can be achieved by galvanizing the interests of public health officials, academia and industry to combat influenza” said Dr Kieny

  • GISAID announces a major contribution from Seqirus

    GISAID today welcomed a €250,000 donation from Seqirus, a leading innovator in influenza vaccine technologies and pandemic response solutions. Seqirus is the first influenza vaccine company to make a significant financial contribution to GISAID.

    Seqirus is proud to support GISAID in its mission to provide open and rapid access to influenza virus data for the public health good of all nations,” said Gordon Naylor, President of Seqirus

    > read more

  • G20 Health Ministers recognize the importance of GISAID in regard to virus data sharing

    At the invitation of Germany, the first meeting of Health Ministers of the Group of Twenty leading industrialized and emerging economies (G20) took place in Berlin between 19-20 May 2017.

    Under the banner of “Together Today for a Healthy Tomorrow – Joint Commitment for Shaping Global Health”, the two-day meeting focused on combating global health hazards. In their Berlin Declaration, the G20 Health Ministers recognize the importance of the Global Initiative on Sharing All Influenza Data (GISAID).

    > read more
    > The Berlin Declaration of the G20 Health Ministers (2017)

  • CBD Study finds 'GISAID might provide useful lessons and insight to ABS discussions'

    A peer-reviewed fact-finding and scoping study on digital sequence information on genetic resources in the context of the Convention on Biological Diversity and the Nagoya Protocol, highlights key advantages of GISAID’s sharing mechanism and a fair and equitable benefit-sharing resulting from access to data.

    With the core principals of timely international sharing of health data for protecting populations against lethal infectious disease outbreaks and adherence to scientific etiquette of acknowledgement of the source of data has resulted in global trust and confidence in GISAID.  > read the full study

  • First study of GISAID shows how it is possible to encourage greater international sharing of data, despite numerous challenges that exist

    A research study by the University of Sussex finds that by developing a successful track-record in the field of influenza, GISAID is contributing to global health in at least five ways:

    (1) collating the most complete repository of high-quality influenza data in the world; (2) facilitating the rapid sharing of information during outbreaks; (3) supporting the World Health Organization's strain selection process for the seasonal flu vaccine; (4) developing mechanisms to resolve potential conflicts concerning the sharing of virus data; and (5) building greater trust with countries that are key to global pandemic preparedness. 

    read more 
    > Data, disease and diplomacy: GISAID's innovative contribution to global health

Public-Private Partnerships of the GISAID Initiative

The GISAID Initiative, also known as a Global Initiative on Sharing All Influenza Data, involves public-private-partnerships between the Initiative's administrative arm Freunde of GISAID e.V., a registered non-profit association, and governments of the Federal Republic of Germany, the official host of the GISAID platform and EpiFlu™ database, Singapore and the United States of America, with support from private and corporate philanthropy.